PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2011; 6(6): e20647.
Published online Jun 6, 2011. doi:  10.1371/journal.pone.0020647
PMCID: PMC3108958
Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis
Volker Mai,#1* Christopher Michael Young,#2 Maria Ukhanova,1 Xiaoyu Wang,1 Yijun Sun,1 George Casella,4 Douglas Theriaque,5 Nan Li,2 Renu Sharma,3 Mark Hudak,3 and Josef Neu2
1Department of Microbiology and Cell Sciences and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America
2Department of Pediatrics, University of Florida, Gainesville, Florida, United States of America
3Department of Pediatrics, University of Florida, Jacksonville, Florida, United States of America
4Department of Statistics and Genetics Institute, University of Florida, Gainesville, Florida, United States of America
5Clinical & Translational Science Institute, University of Florida, Gainesville, Florida, United States of America
Dipshikha Chakravortty, Editor
Indian Institute of Science, India
#Contributed equally.
* E-mail: vmai/at/ufl.edu
Conceived and designed the experiments: VM JN RS MH GC DT. Performed the experiments: VM CMY MU LN JN RS MH. Analyzed the data: VM CMY JN DT XW YS MU LN RS MH GC. Contributed reagents/materials/analysis tools: VM JN RS. Wrote the paper: VM CMY JN RS MH GC XW. Bioinformatics/stats tool development: XW YS GC.
Received March 8, 2011; Accepted May 5, 2011.
Intestinal luminal microbiota likely contribute to the etiology of necrotizing enterocolitis (NEC), a common disease in preterm infants. Microbiota development, a cascade of initial colonization events leading to the establishment of a diverse commensal microbiota, can now be studied in preterm infants using powerful molecular tools. Starting with the first stool and continuing until discharge, weekly stool specimens were collected prospectively from infants with gestational ages ≤32 completed weeks or birth weights≤1250 g. High throughput 16S rRNA sequencing was used to compare the diversity of microbiota and the prevalence of specific bacterial signatures in nine NEC infants and in nine matched controls. After removal of short and low quality reads we retained a total of 110,021 sequences. Microbiota composition differed in the matched samples collected 1 week but not <72 hours prior to NEC diagnosis. We detected a bloom (34% increase) of Proteobacteria and a decrease (32%) in Firmicutes in NEC cases between the 1 week and <72 hour samples. No significant change was identified in the controls. At both time points, molecular signatures were identified that were increased in NEC cases. One of the bacterial signatures detected more frequently in NEC cases (p<0.01) matched closest to γ-Proteobacteria. Although this sequence grouped to the well-studied Enterobacteriaceae family, it did not match any sequence in Genbank by more than 97%. Our observations suggest that abnormal patterns of microbiota and potentially a novel pathogen contribute to the etiology of NEC.
Necrotizing enterocolitis (NEC) is a devastating disease with a multi-factorial etiology that affects primarily premature infants and carries a huge burden in terms of mortality, morbidity, and cost to society.[1] One hypothesis suggests that a major etiological factor for NEC is colonization of the neonatal gut with an abnormal microbiota,[2] particularly as NEC typically occurs after days 8–10 d postpartum when anerobic bacteria commonly start to colonize the gut. Furthermore, NEC has not been observed in germfree animals [3] and infants with NEC frequently exhibit concomitant bacteremia and endotoxemia.[4] Although various microbes have been cultured from blood and stools in outbreaks of NEC at single institutions, no single organism has consistently been implicated across centers.[3] The human microbiome project,[5] in conjunction with technologic advances that allow for the molecular identification of a vast array of microbes that are difficult or impossible to culture from the intestine,[6], [7] has given us new tools for generating evidence supporting the “abnormal colonization hypothesis”.[8] Studies have shown that multiple environmental factors affect microbiota development,[9] and others have suggested that modification of the microbiota may confer clinical benefits.[10] Preliminary studies have evaluated fecal microbiota from unaffected preterm infants and from infants with NEC both prior to and during NEC.[11], [12] These studies suggest an association between the pattern of intestinal microbial species and NEC.
In this study, we compared the intestinal microbiota in 9 premature infants with NEC to that of 9 matched and unaffected control infants.
Patients
Preterm infants were enrolled from three University of Florida affiliated hospitals. We studied infants with birth weights less than or equal to 1,250 grams and gestational ages less than or equal to 32 completed weeks. Infants with known congenital malformations of the intestine such as gastroschisis or atresias, and infants that were not expected to survive beyond the first week, were excluded. All infants who met the inclusion criteria were enrolled in the study shortly after birth. Informed written consent was obtained from a parent by the attending physicians or research nurses at each site. The study was approved by the Institutional Review Boards at the University of Florida.
Nine of the approximately 200 babies enrolled in the study to date met the criteria for diagnosis of NEC (Bell Stage 2 or 3 with radiologic pneumatosis intestinalis and/or portal venous gas; or direct intra-operative confirmation of intestinal pathology). [13], [14] Control infants were selected and matched to NEC case infants using gestational age, birth weight, birth center, date of birth (+/− 2 months), and predominant enteral nutrient (breast milk vs.. formula).
Samples
Beginning with the first stool and continuing until discharge, we collected weekly stool samples from study infants for immediate storage at −80°C. The samples that were selected to be analyzed from cases were those collected one week “prior” (median 7 days, range 3–10 days) to the onset of NEC (and at equivalent time points in controls), and those that were collected most “proximate” to the occurrence of NEC (all were within 72 hours of NEC onset). Samples from control infants were chosen at the same week of life at which the samples from the matched cases were obtained.
Microbiota Analysis
DNA extraction and quality control by denaturing gradient gel electrophoresis (DGGE)
DNA was extracted from 200–300 mg fecal samples using a modified Qiagen stool DNA extraction protocol that included a bead beating step.[15] We used DGGE analysis of the V6–V8 region as described previously,[12] for initial quality control.
16S rRNA sequence analysis
DNA was amplified using a barcoded primer set based on universal primers 27F and 338R as described by Hamady et al.[16] Cleaned PCR products were pooled in equimolar amounts and submitted for sequencing using 454 Flex chemistry. From the resulting raw data set, low quality sequences or sequences with a length less than 100 nucleotides were removed. Sequences were initially analyzed using the Ribosomal Database Project (RDP) pyrosequencing pipeline that included features to calculate diversity indices and rarefaction curves. We then used the ESPRIT algorithm [17] to bin sequences into Operational Taxonomic Units (OTUs) using similarity levels from 99% (species/strain level) to 80% (phylum level). We used the QIIME package [18] to calculate i) Chao rarefaction diversity, which estimates how many OUT's are present in a sample, and ii) UniFrac distances [19] , which allow for a comparison of the distribution of OUT's among samples.
Statistics
Student's t-test was used when data were normally distributed; otherwise a paired chi square test followed by Fisher combining was used to test for a difference in the prevalence of OTUs. We adjusted for an expected high false discovery rate by increasing the requirement for statistical significance to p<0.01. The QIIME package was used to calculate p-values for differences in UniFrac distances.
Patient Characteristics
The mean gestational age of all infants was 26.7 weeks (range, 23 to 30 weeks) and mean birth weight was 960 grams (range, 570 to 1,269 grams), There were 4 females and 5 males in the NEC group and 5 females and 4 males in the control group (Table 1). In each group, four infants were delivered by cesarean section. While all of the cases received multiple antibiotics during the two weeks prior NEC diagnosis, four of the five controls did not receive any antibiotics at the matched period of life. There was no significant differences in predominant diet (breast milk vs. formula) in the infants with and without NEC prior to the development of the disease.
Table 1
Table 1
Characteristics of study subjects.
Microbiota Analysis
After processing and screening of specimens, we analyzed a total of 110,021 sequences that represented an average of 3,056 sequences per sample (range, 1,822–5,625). The average length per sequence was 233 nucleotides (range, 100–292).
We then clustered sequences using ESPRIT at the 98%, 95% and 90% similarity levels to obtain OTUs containing similar sequences for further microbiota analysis. ESPRIT uses a novel alignment algorithm that performs pairwise rather than multiple sequence alignment. In its current implementation it has been shown to improve alignment quality over other commonly used algorithms that include CD-Hit and Uclust. Before removing singletons (OTUs that contain only one sequence) we had 11510, 771 and 350 OTUs at the respective similarity levels. After removal of singletons we retained 7768, 587 and 279 OTUs respectively. To reduce loss of statistical power due to multiple comparisons, we removed all OTUs with less than five sequences. We retained 2636, 365 and 184 OTUs at the respective similarity levels for analysis.
Using these binned sequence data, we first analyzed microbiota structure and diversity with microbial ecology tools available in the QIIME package. The total numbers of OUT's present, as estimated using Chao1-based rarefaction curves (a common measure of diversity in populations) did not differ between cases and controls at either of the two time points (Figure 1). When we analyzed overall composition using the UniFrac metric (unweighted), which is based on branch length differences between the case/control groups in a phylogenetic tree generated from all 16S rRNA sequences, we detected that one week before NEC diagnosis seven out of the nine control samples clustered closely together, whereas the nine NEC case samples were quite distant from each other (Fig. 2A). We did not observe the same in the samples collected during the week of NEC diagnosis (Fig. 2B). Although diversity indices, which are calculated based on the number and distribution of observed OUT's, did not differ at either time point, there was more variation in overall microbiota structure in NEC infants one week before diagnosis whereas microbiota was more similar in most controls.
Figure 1
Figure 1
Chao rarefaction diversity.
Figure 2
Figure 2
Unifrac diversity measures.
We next analyzed differences in the proportion of bacterial groups at the phylum level. Four phyla (Firmicutes, Proteobacteria, Bacteroidetes and Actinobacteria) dominated the microbiota in most samples (Figure 3). The proportion of Actinobacteria and Bacteroidetes was lower in NEC than in control infants. We observed a 34% increase in the proportion of Proteobacteria in NEC infants at the expense of a 32% decrease in Firmicutes that occurred over the week before the diagnosis of NEC. In contrast, the proportions of the four major bacterial phyla in control infants did not change significantly over the same time period. In NEC infants Firmicutes dominated at the earlier time point. A late bloom of Palong with continuously low numbers of Actinobacteria and Bacteroidetes was observed in NEC infants during the week prior to diagnosis of NEC.
Figure 3
Figure 3
Changes in proportion of bacterial phyla.
Finally, as an exploratory analysis, we compared the distribution of OTUs between the two groups at both time points. In the hypervariable region of the 16S rRNA that we analyzed, a similarity level of 98% might equate to the level of strain, a similarity level of 95% to the species level, and 90% similarity to the genus level. At the 98% level, a variety of OTUs were more frequently detected (p<0.01) in cases compared to controls (Figure 4). In contrast to other microbiota studies in older children and adults where most of the ‘unknown’ OTUs group to the phylum Firmicutes or Bacteroidetes, we detected a particular ‘unknown’ OTU that grouped to the γ-Proteobacteria. This OTU was detected in 3/9 NEC cases but in none of the controls (p<0.01). This OTU appears most closely related to the Enterobacteriaceae, a family that contains many known pathogens and accordingly has been extensively studied. Surprisingly, although the OTU matched this well-studied family, no strains in the database achieved more than a 97% match. In addition to this ‘unknown’ OUT' we detected a variety of other OTUs at the time of diagnosis that were found only in NEC infants. These OTUs grouped closest to known Enterobacteriaceae (Cronobacter muytjensii, Escherichia coli, Enterobacter sp.; Klebsiella pneumoniae) and to Staphylococcus epidermidis.
Figure 4
Figure 4
Differences in OTU abundance.
The healthy adult human harbors roughly 1×1014 bacteria in the intestinal tract and these organisms make up about 60% of the total fecal mass.[20] Derangements in the numbers or types of bacteria can affect health and influence disease states. While human data are just starting to emerge, animal studies have suggested that microbiota composition in the neonatal period may affect gastrointestinal (GI) tract development, mucosal integrity, and even nutritional status.[21], [22] Thus, developing an understanding of the neonatal (especially the very preterm) microbiota would be invaluable in helping to elucidate the processes that promote health or alternatively predispose to diseases, such as NEC.
In contrast to an earlier report that suggested reduced microbiota diversity in samples collected from cases after NEC diagnosis and a distinct clustering when compared with matched controls,[11] we did not detect such differences in overall diversity measures in our study. Rather, our findings confirm and extend our earlier observation that overall microbiota diversity at the time of diagnosis does not differ between healthy preterm infants and infants with NEC.[23] Our observation that one week before diagnosis microbial structure was more heterogeneous in infants that developed NEC suggests the potential for early detection of risk and focused intervention. Based on the data presented here it is feasible that future studies that include more cases will allow for the identification of a “high risk” microbiota pattern based on discriminant analysis of 16S rRNA sequences.[24]
We used high throughput sequencing in a prospective study design. Our sequence depth per subject was more than 20 times deeper than that previously reported [11] allowing us to detect rare OTUs that would have been missed with less extensive sequencing. We did confirm the presence of a higher proportion of Proteobacteria that the same group reported only after the diagnosis of NEC. [11] Furthermore, we observed that the proportion of Proteobacteria increased in samples collected from NEC infants over the week prior to the diagnosis of NEC. In the samples collected from the NEC infants one week before diagnosis, the proportion of Proteobacteria was actually lower than that observed in the matched control samples. Hence, our data raise the possibility that preterm infants not sufficiently colonized with Proteobacteria during the first weeks of life during which early immune protection or tolerance might develop, may not be able to modulate an adaptive immunological response to a subsequent bloom of Proteobacteria, and instead develop intestinal pathology consistent with NEC.
A recently published study[25] reported that, using similar sequencing techniques, less than 10% of healthy infants carried Enterobacteria until the sixth week of life when a bloom occurred. Our study went further as we detected specific OTUs that increased in NEC infants during the week prior to diagnosis. Most of these OTUs grouped to the Enterobacteriaceae, and represented both known and unknown species. An OTU matching S. epidermidis, a common skin commensal, was also exclusively detected in infants with NEC.
We could not confirm a report by others that suggested a contribution of clostridia species and their toxins to NEC.[26] We did not observe an association of NEC risk with the presence of Citrobacter like sequences or the frequency of Enterococcusas suggested in preliminary studies.[12] However, in the current study we have sufficient power for detecting differences between groups in any OUT's that contributed at least 0.5% to the overall microbiota in the majority of samples from cases or controls.
Our observations regarding any of the OUT's that were more frequently detected in cases should be interpreted with caution. We initially compared distributions of more than a thousand OUT's. Even after removal of rare OUT's we retained many hundreds of OUT's in our analysis. Due to the exploratory character of our study we did not correct for multiple analyses, although we did lower the significance level to p<0.01. Thus, we cannot exclude the possibility that some of our findings did occur by chance. Furthermore, as we studied microbiota development only in preterm infants born in Florida, our findings cannot necessarily be generalized to other populations.
Among the many OTUs that we evaluated we did detect an increase in the numbers of a particular OTU that matched closest to the Enterobacteriaceae. When we searched Genbank for the closest match using a blast search, we did not detect any sequence that matched this OTU by more than 97%. This is an intriguing observation because the Enterobacteriaceae family is particularly well-studied and contains many established enteric pathogens that harbor a variety of known virulence factors. Our finding is consistent with the hypothesis that a novel pathogen might be an important etiologic factor in at least a subset of infants with NEC. One line of evidence that provides support for the notion that this organism belongs to a class of microbes that has special pathogenic characteristics involves the lipid A moiety of the cell wall LPS, which is known to differ between organisms. Animals use the TLR4 receptor mechanism to recognize the lipid A moiety of LPS. LPS recognition and pro-inflammatory signaling by TLR4 occurs only when lipid A has a certain structure; it contains both phosphates and is a hexaacyl.[27] In the Bacteroidetes that sometimes dominate the gut microbiota in adults, the LPS is pentacylated, making it a less efficient activator of the TLR4 mechanism leading to decreased immunogenicity.[28] However in Proteobacteria, the lipid A is hexacylated, making it a potent agonist for the TLR4 system and thus more immunogenic. During times of health, the immunogenic properties of the LPS of Proteobacteria are muted by the overwhelming predominance of Bacteroidetes and Firmicutes. However, during inflammation (as occurs in diseases such as NEC), there is a relative decrease in the presence of these less immunogenic bacteria and a relative increase in Proteobacteria, as shown by our results.
In addition to specific OTUs that appeared to be associated with NEC we also detected a bloom in Proteobacteria unique to the NEC infants. Our observations require confirmation in further studies and with different methodologies. Such studies are currently ongoing at our institution and elsewhere as part of the Human Microbiome Project. We are hopeful that a better understanding of NEC etiology from such studies might be rapidly translated into better diagnostic tools and prophylactic interventions that will meaningfully reduce the incidence and severity of NEC in preterm infants.
Acknowledgments
We would like to thank participants and staff at the respective NICU's for their support of this study.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: This work was supported by the National Institute of Child Health and Human Development, grant number RO1 HD 059143 and the National Institutes of Health (NIH) and National Center for Research Resources (NCRR) CTSA grant 1UL 1RR029890. Dr. Mai was also supported by a grant from the American Cancer Society MRSGT CCE-107301. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364:255–264. [PubMed]
2. Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J. 2001;15:1398–1403. [PubMed]
3. Morowitz MJ, Poroyko V, Caplan M, Alverdy J, Liu DC. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics. 2010;125:777–785. [PubMed]
4. Schwiertz A, Gruhl B, Lobnitz M, Michel P, Radke M, et al. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res. 2003;54:393–399. [PubMed]
5. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. The human microbiome project. Nature. 2007;449:804–810. [PubMed]
6. Riesenfeld CS, Schloss PD, Handelsman J. Metagenomics: genomic analysis of microbial communities. Annu Rev Genet. 2004;38:525–552. [PubMed]
7. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol. 2008;24:4–10. [PubMed]
8. Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res. 2009;16:1–12. [PMC free article] [PubMed]
9. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Development of the Human Infant Intestinal Microbiota. PLoS Biol. 2007;5:e177. [PMC free article] [PubMed]
10. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125:921–930. [PubMed]
11. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3:944–954. [PMC free article] [PubMed]
12. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, et al. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr. 2010;156:20–25. [PubMed]
13. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179–201. [PubMed]
14. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7. [PubMed]
15. Mai V, Greenwald B, Morris JG, Jr, Raufman JP, Stine OC. Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota composition. Gut. 2006;55:1822–1823. [PMC free article] [PubMed]
16. Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods. 2008;5:235–237. [PubMed]
17. Sun Y, Cai Y, Liu L, Yu F, Farrell ML, et al. ESPRIT: estimating species richness using large collections of 16S rRNA pyrosequences. Nucleic Acids Res. 2009;37:e76. [PMC free article] [PubMed]
18. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336. [PubMed]
19. Lozupone C, Hamady M, Knight R. UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics. 2006;7:371. [PMC free article] [PubMed]
20. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688–693. [PubMed]
21. Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol. 2006;21:517–523. [PubMed]
22. Caicedo RA, Schanler RJ, Li N, Neu J. The developing intestinal ecosystem: implications for the neonate. Pediatr Res. 2005;58:625–628. [PubMed]
23. Mshvildadze M, Neu J, Mai V. Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship? Nutr Rev. 2008;66:658–663. [PubMed]
24. Sun Y, Cai Y, Mai V, Farmerie W, Yu F, et al. Advanced computational algorithms for microbial community analysis using massive 16S rRNA sequence data. Nucleic Acids Res. 2010;38:e205. [PMC free article] [PubMed]
25. Jacquot A, Neveu D, Aujoulat F, Mercier G, Marchandin H, et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr. 2011;158:390–396. [PubMed]
26. De La Cochetiere MF, Piloquet H, des RC, Darmaun D, Galmiche JP, et al. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res. 2004;56:366–370. [PubMed]
27. Munford RS, Varley AW. Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog. 2006;2:e67. [PMC free article] [PubMed]
28. Coats SR, Do CT, Karimi-Naser LM, Braham PH, Darveau RP. Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site. Cell Microbiol. 2007;9:1191–1202. [PubMed]
Articles from PLoS ONE are provided here courtesy of
Public Library of Science